戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  fluids as a result of P450 7A1 oxidation of 7-dehydrocholesterol.
2 rs of ecdysone biosynthesis, cholesterol and 7-dehydrocholesterol.
3 d in skin through ultraviolet irradiation of 7-dehydrocholesterol.
4                                              7-Dehydrocholesterol (7-DHC) is the most oxidizable lipi
5       Children with SLOS have elevated serum 7-dehydrocholesterol (7-DHC) levels and typically have l
6 ized by diminished cholesterol and increased 7-dehydrocholesterol (7-DHC) levels.
7 nts have decreased cholesterol and increased 7-dehydrocholesterol (7-DHC) levels.
8            A mammalian analog of ergosterol, 7-dehydrocholesterol (7-DHC), accumulates in Smith-Lemli
9 n with standard, the identity of this ion is 7-dehydrocholesterol (7-DHC), an immediate dehydrogenate
10 radical chain oxidation of highly oxidizable 7-dehydrocholesterol (7-DHC), initiated by 2,2'-azobis(4
11 The mechanism of free radical oxygenation of 7-dehydrocholesterol (7-DHC), one of the biologically im
12 d adrenals produced robust transformation of 7-dehydrocholesterol (7-DHC; precursor to cholesterol an
13 d an accumulation of its metabolic precursor 7-dehydrocholesterol (7DHC) in developing tissues.
14 hether novel pathways of vitamin D3 (D3) and 7-dehydrocholesterol (7DHC) metabolism initiated by CYP1
15 in the Kandutsch-Russell pathway, converting 7-dehydrocholesterol (7DHC) to cholesterol.
16 ions in DHCR7, which impair the reduction of 7-dehydrocholesterol (7DHC) to cholesterol.
17                     The vitamin D precursor, 7-dehydrocholesterol (7DHC), was significantly lower in
18 urprisingly ergosterol, a fungal sterol, and 7-dehydrocholesterol, a sterol present in elevated level
19 e potently reversed by crude lipid extracts, 7-dehydrocholesterol, and a recently identified DAF-12 s
20   In addition, we describe the metabolism of 7-dehydrocholesterol by CYP11A1 to a single product iden
21             After feeding BM 15.766, hepatic 7-dehydrocholesterol delta 7-reductase activity decrease
22 piperazin-4-yl]ethyl]-benzoic acid) inhibits 7-dehydrocholesterol delta 7-reductase activity, reduces
23 ed birth disorder caused by markedly reduced 7-dehydrocholesterol delta 7-reductase activity, the fin
24  reductase, lathosterol 5-dehydrogenase, and 7-dehydrocholesterol delta 7-reductase are down-regulate
25 tic pathway, lathosterol 5-dehydrogenase and 7-dehydrocholesterol delta 7-reductase, were measured.
26  pathway catalyzed by the microsomal enzyme, 7-dehydrocholesterol-delta 7-reductase.
27 , lovastatin, and BM 15.766, an inhibitor of 7-dehydrocholesterol delta7-reductase, and were compared
28 unable to produce cholesterol and accumulate 7-dehydrocholesterol (DHC) in serum and tissue.
29 e catalyzes the conversion of lathosterol to 7-dehydrocholesterol in the next to last step of cholest
30 old increase of the 27-hydroxy metabolite of 7-dehydrocholesterol in the plasma of children with Smit
31    The content of the vitamin D(3) precursor 7-dehydrocholesterol in the skin of obese and nonobese s
32  Solar ultraviolet B photons are absorbed by 7-dehydrocholesterol in the skin, leading to its transfo
33  in the pathway, lead to the accumulation of 7-dehydrocholesterol in tissues and fluids of SLOS patie
34 ncentrations reduced 25%, and the precursor, 7-dehydrocholesterol, increased to represent 71% of the
35                             The finding that 7-dehydrocholesterol is a precursor of 7-ketocholesterol
36                                              7-Dehydrocholesterol is highly reactive, giving rise to
37 holesterol (k(p)= 11 +/- 2 M(-1) s(-1)), and 7-dehydrocholesterol (k(p)= 2260 +/- 40 M(-1) s(-1)).
38 d or lovastatin could reduce elevated plasma 7-dehydrocholesterol levels induced by BM 15.766.
39 ces plasma cholesterol levels, and increases 7-dehydrocholesterol levels to reproduce the biochemical
40 ls and a marked increase of serum and tissue 7-dehydrocholesterol levels.
41                             The oxidation of 7-dehydrocholesterol occured with predominant formation
42 he consequences of the extreme reactivity of 7-dehydrocholesterol on human health is the focus of a c
43                             The mechanism of 7-dehydrocholesterol oxidation to 7-ketocholesterol is p
44              Mutations in the gene for Delta(7)-dehydrocholesterol reductase (Delta(7)-reductase), wh
45 shed by a strong and selective inhibition of 7-dehydrocholesterol reductase (7-DHCR, EC 1.3.1.21), an
46 rol reductase (C14SR, also known as TM7SF2), 7-dehydrocholesterol reductase (DHCR7) and 24-dehydrocho
47                                              7-Dehydrocholesterol reductase (DHCR7) is the terminal e
48 pitz syndrome (SLOS) is caused by defects in 7-dehydrocholesterol reductase (DHCR7), an enzyme cataly
49 encoding the cholesterol biosynthetic enzyme 7-dehydrocholesterol reductase (DHCR7).
50 fferent autosomal recessive mutations of the 7-dehydrocholesterol reductase gene leading to deficient
51                            Since a defect of 7-dehydrocholesterol reductase is associated with Smith-
52 1790349, located in DHCR7, the gene encoding 7-dehydrocholesterol reductase that synthesizes choleste
53           Mutations within the gene encoding 7-dehydrocholesterol reductase, the last enzyme in the p
54 sterol levels dropped 75% and the precursor, 7-dehydrocholesterol rose substantially.
55  reductase that synthesizes cholesterol from 7-dehydrocholesterol; rs6599638 in the region harboring
56 d with various sterols, only desmosterol and 7-dehydrocholesterol supported internalization.
57 76% and was associated with a marked rise of 7-dehydrocholesterol that could be almost entirely preve
58 esterol have been established, we found that 7-dehydrocholesterol (the immediate precursor of cholest
59 free radical propagation rate constants, and 7-dehydrocholesterol, the immediate biosynthetic precurs
60 nd relative plasma cholesterol, but not with 7-dehydrocholesterol, the immediate precursor, confirmin
61 aenoate (20:5), docosahexaenoate (22:6), and 7-dehydrocholesterol to be 115 +/- 7, 145 +/- 8, 172 +/-
62 y rat liver microsomes, of the conversion of 7-dehydrocholesterol to cholesta-5,8-dien-3 beta-ol is a
63  an enzyme responsible for the conversion of 7-dehydrocholesterol to cholesterol in the last step of
64                            The conversion of 7-dehydrocholesterol to cholesterol is the last reaction
65 tase gene leading to deficient conversion of 7-dehydrocholesterol to cholesterol, the RSH (so-called
66 ations of DHCR7 that impair the reduction of 7-dehydrocholesterol to cholesterol.
67 olet B light we found that the conversion of 7-dehydrocholesterol to previtamin D3 was reduced in chi
68  7A1 converted lathosterol (Delta(5)-dihydro-7-dehydrocholesterol) to a mixture of the 7-keto and 7al
69          In some experiments, cholesterol or 7-dehydrocholesterol was incorporated into the lipid mix
70                          Ampoules containing 7-dehydrocholesterol were exposed to a LED that emitted
71 containing 7-8 double bonds (lathosterol and 7-dehydrocholesterol) were better raft stabilizers than

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。